Medicare Enrolled

Dr. James Dooner, MD

Ophthalmology · Austin, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
801 W 38TH ST, Austin, TX 78705
5124510103
In practice since 2006 (20 years)
NPI: 1962474643 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dooner from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dooner? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dooner

Dr. James Dooner is an ophthalmology specialist in Austin, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dooner performed 14,659 Medicare services across 3,506 unique beneficiaries.

Between the years covered by Open Payments, Dr. Dooner received a total of $7,485 from 30 pharmaceutical and/or device companies across 130 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dooner is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 7% volume in TX $7,485 industry payments

Medicare Practice Summary

Medicare Utilization ↗
14,659
Medicare services
Top 7% in TX for ophthalmology
3,506
Unique beneficiaries
$197
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~733 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab) 3,660 $29 $84
Aflibercept eye injection (Eylea) 2,782 $692 $2,000
Retinal imaging (OCT scan) 2,208 $29 $125
Eye injection for retinal disease 1,630 $95 $550
Injection, pegcetacoplan, intravitreal, 1 mg 795 $120 $336
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg 617 $206 $1,000
Office visit, established patient (20-29 min) 592 $63 $200
Retinal photography (fundus photo) 409 $27 $95
Exam of retinal blood vessels using a special camera after injection of a dye 373 $105 $270
Injection, ranibizumab, 0.1 mg 365 $179 $800
Comprehensive eye exam, established patient 343 $84 $265
Injection, bevacizumab, 10 mg 208 $53 $150
Office visit, established patient (30-39 min) 196 $87 $270
Comprehensive eye exam, new patient 161 $107 $315
New patient office visit (45-59 min) 82 $120 $350
Unclassified drugs 82 $1,747 $5,071
Eye exam, established patient, focused 81 $67 $190
2d ultrasound scan of eye tissue and structures 25 $36 $150
Removal of membrane of retina with removal of internal limiting membrane of retina 23 $883 $2,310
Removal of eye fluid (vitreous) between lens and retina 14 $579 $1,820
Photocoagulation treatment to prevent detachment of retina 13 $183 $750
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,485
Total received (2018-2024)
Avg $1,069/year across 7 years
Top 16% in TX for ophthalmology
30
Companies
130
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,925 (79.2%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$1,560 (20.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,303
2023
$775
2022
$1,271
2021
$756
2020
$550
2019
$1,524
2018
$1,306

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
US Retina LLC
$1,560
Genentech USA, Inc.
$728
Genentech, Inc.
$688
Regeneron Healthcare Solutions, Inc.
$606
Alimera Sciences, Inc.
$513
Harrow Eye, LLC
$365
Allergan Inc.
$296
Apellis Pharmaceuticals, Inc.
$258
Regeneron Pharmaceuticals, Inc.
$249
Johnson & Johnson Surgical Vision, Inc.
$223
TissueTech, Inc.
$218
ABBVIE INC.
$198
Novartis Pharmaceuticals Corporation
$187
Carl Zeiss Meditec, Inc.
$176
Astellas Pharma US Inc
$163
Bausch & Lomb, a division of Bausch Health US, LLC
$137
Bausch & Lomb Americas Inc.
$132
Astellas Pharma Global Development
$131
Mallinckrodt Enterprises LLC
$119
OPTOVUE, INC.
$100
Spark Therapeutics, Inc.
$99
OPTOS, INC.
$84
AbbVie Inc.
$77
Biogen, Inc.
$64
Allergan, Inc.
$29
Sun Pharmaceutical Industries Inc.
$25
EyePoint Pharmaceuticals US, Inc.
$21
Amgen Inc.
$16
Dutch Ophthalmic, USA
$14
Retrophin, Inc.
$10
Top 3 companies account for 39.8% of total payments
Associated products mentioned in payments ›
(820) Cholbam · ACTHAR · BEOVU · BYOOVIZ · BromSite (bromfenac ophthalmic solution) 0.075% · CLARUS · EVA Ophthalmic Surgical System · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · IHEEZO · ILUVIEN · Izervay · LUMIGAN · LUXTURNA · Lucentis · Non-Covered Product · OZURDEX · P200DTx · Prokera · STELLARIS PC · SUSVIMO · Stellaris · Syfovre · TEPEZZA · Tecnis Multifocal Family of 1-piece IOLS · Tecnis Simplicity · VABYSMO · Vabysmo · XIPERE · XR · YUTIQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (79%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $51 per 100 Medicare services performed
Looking for an ophthalmology specialist in Austin?
Compare ophthalmologists in the Austin area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
133
Per 100K population
10.2
County median income
$97,169
Nearest hospital
ASCENSION SETON MEDICAL CENTER AUSTIN
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Dooner is a mixed practice specialist, with above-average Medicare volume (top 7% in TX), with low-engagement industry engagement in the top 16% of TX peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Dooner experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Dooner performed 3,660 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dooner receive payments from pharmaceutical companies?
Yes. Dr. Dooner received a total of $7,485 from 30 companies across 130 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dooner's costs compare to other ophthalmologists in Austin?
Dr. Dooner's average Medicare payment per service is $197. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dooner) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →